Blossomhill Therapeutics, Inc. · NASDAQ:BLSM
Orbimed Advisors LLC reported a 8.90% stake in Blossomhill Therapeutics, Inc. (Schedule 13D)
Event Aug 10, 2026 · Filed Aug 18, 2026
Orbimed Advisors LLC reported a 8.90% stake in Blossomhill Therapeutics, Inc., 2,714,279 shares, with active intent on Aug 10, 2026. Filed Aug 18, 2026 (Schedule 13D).
- Stake
- 8.90%
- Shares
- 2,714,279
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ORBIMED ADVISORS LLC | 8.90% | 2,714,279 |
| OrbiMed Capital GP VIII LLC | 8.90% | 2,714,279 |
Source
Related
- Blossomhill Therapeutics, Inc.
- Orbimed Advisors LLC
- Blossomhill Therapeutics, Inc. shareholders
- Schedule 13G · Vivo Innovation Fund II Holdings, L.P. · Aug 17, 2026
- Schedule 13G · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13D · Chen Bihua · Aug 13, 2026
- Form 4 · Gordon Carl L · Aug 12, 2026
- Form 4 · OrbiMed Capital GP VIII LLC · Aug 12, 2026